BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

GE Capital Provides $4.5 Million Credit Facility to QSpex Technologies, Inc.


7/12/2010 8:02:24 AM

BETHESDA, Md.--(BUSINESS WIRE)--GE Capital, Healthcare Financial Services today announced it has provided a $4.5 million credit facility to QSpex Technologies, Inc. The financing provides working capital and funds capital equipment expenditures supporting QSpex's product launch in late 2010.

Based in Alpharetta, GA, QSpex Technologies, Inc. Lens Transformation Technology delivers a high quality in-office solution for eyecare professionals across the U.S. to produce prescription eyeglass lenses faster, easier, less expensively and more profitably than current options available on the market.

"GE Capital’s healthcare industry expertise and professionalism were instrumental in this transaction," said Dennis Carr, vice president of finance for QSpex Technologies, Inc. “Working with a trustworthy lender gave us confidence that our financing needs were as important to GE as they are to us.”

“We are pleased to be able to provide capital to QSpex Technologies, Inc. to support this important product launch,” said Anthony Storino, senior managing director, life sciences, for GE Capital, Healthcare Financial Services. “GE’s combination of healthcare and financial expertise can provide our customers with unmatched resources to reach their critical business objectives.”

About GE Capital, Healthcare Financial Services

With over $17 billion invested in more than 30 sub-sectors including senior housing, hospitals, pharmaceuticals, and medical devices, GE Capital, Healthcare Financial Services is a premier provider of capital and services to the healthcare industry. Our team of professionals provides deep industry expertise to create business and financial solutions tailored to meet the individual needs of our customers. The Life Science Finance team has worked with more than 500 companies throughout the United States, Canada and Europe. With a dedicated focus on assisting life science companies large and small, from the first venture round to post-IPO, the team has provided over $2.5 billion in financing to the market. For more information, visit www.gecapital.com/healthcare.

GE Capital offers consumers and businesses around the globe an array of financial products and services. For more information, visit gecapital.com or follow company news via Twitter (@GECapital). GE (NYSE: GE - News) is a diversified infrastructure, finance and media company taking on the world’s toughest challenges. Visit ge.com.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES